Sarah’s research expertise is in the genetic and genomic epidemiology of malaria. Her current research focus entails utilising information on the genetic make-up of the malaria parasite Plasmodium vivax to gain insights into the biological mechanisms underlying antimalarial drug resistance, and to monitor the parasite’s transmission dynamics within and across borders.
Ultimately, her goal is to utilise this information to develop global maps of drug resistance and transmission, highlighting major hotspots and key routes of spread, to guide more efficient strategies to control and eliminate malaria.
As a research support officer in the Asia Pacific Malaria Elimination Network (APMEN), a key component of Sarah’s work is to provide capacity building support to researchers in malaria endemic countries. Mediated by this role, Sarah has established collaborations with researchers from a range of countries enabling the development of a network to support global P. vivax genetic epidemiology studies.
In collaboration with partners at the Wellcome Trust Sanger Institute, Sarah is also involved in genomic studies to identify subsets of genetic variants (barcodes) for mapping P. vivax drug resistance and transmission.